RxDoctor Payments Data

Bryan Danhires, DPM

Podiatrist · Morgantown, WVNPI 1134232879

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 71.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,783 and has fallen 78.9% since, to $376 in 2025.

$2,352in general payments, 2019–2025

Across 35 payments — averaging $67.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$2K
  • Polarityte, Inc.$290
  • Organogenesis Inc.$148
  • AbbVie$71
  • Smith+Nephew$64
  • Johnson & Johnson$40
  • plus $69 from 3 others

What the payments were for

  • Speaking & faculty fees$823%
  • Travel & lodging$1,09747%
  • Food & beverage$1,17350%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,352 in reported general payments places this provider in the 70th percentile of 37 podiatrist providers in West Virginia.

See all podiatrist providers in West Virginia

Medicare billing

Part B allowed, 2024
$54,330
Medicare patients
345
Services billed
785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox36$769
Ammonium Lactate29$666
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip22$518
Terbinafine Hcl58$448
Colchicine11$264
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen49$248
Gabapentin19$198
Cephalexin23$194
Clindamycin Hcl15$170
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$102

Paid to pharmacies, not to this prescriber.

Other podiatrist in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →